跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allercef - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Allercef
Approved
STANDARD
Allercef
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf0066d18ca6dc76
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
bf0066d18ca6dc76
Drug Approval Philippines Name
Allercef
Product Name
Allercef
Registration Number
DRP-1317-06
Brand Name
Allercef
Generic Name
Cetirizine Dihydrochloride
Dosage Form
Oral Solution
Dosage Strength
1 mg/mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
EURO-HEALTH CARE EXPONENTS, INC.
Distributor
Altomed Pharmaceuticals, Inc.
Issuance Date
28 April 2022
Expiry Date
04 May 2027
Pharmacologic Category
Antihistamine (Piperazine Derivative)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf0066d18ca6dc76
Type
Standard
Back to Philippines FDA Approvals